Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

Completed

Conditions studied: Cervical Cancer

In brief

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cervical cancer patients. We believe that some of these markers may be useful in selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Key facts

Study ID

NCT01546363

Run by

Stanford University

People needed

95

Starts

2012-02-24

Expected to finish

2020-06-29

Last updated by the study team

2020-10-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have a known or suspected cervical cancer.
• Age >=18 years.
• Patients must have no other active cancer at the time of diagnosis.
• Patients must have no history of a hysterectomy.
• Patients must be able to give informed consent.
• Patients must be willing to undergo a biopsy of the cervical tumor to provide tissue for the study.
• Patients must have completed a standard-of-care FDG-PET/CT prior to initiation of therapy, for assessment of lymph nodes.

You may not qualify if…

• Pregnant women

Where it is running

• Stanford University, School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.